Overview

A Clinical Study of Personalized Self-DC Vaccine Targeting Neoantigen in Treatment of Advanced Solid Tumor

Status:
RECRUITING
Trial end date:
2025-09-30
Target enrollment:
Participant gender:
Summary
This is a clinical study of personalized self-DC vaccine targeting neo-antigen (Neo-DC vaccine) in the treatment of advanced solid tumors.
Phase:
NA
Details
Lead Sponsor:
Fudan University
Treatments:
lentiviral minigene vaccine of COVID-19 coronavirus